Bio-Techne (TECH) Stock

On February 4, 2025, Bio-Techne Corporation (NASDAQ: TECH) based in Minneapolis, announced that they have appointed Dr. Amy E. Herr.

In the second quarter, Bio-Techne is likely to have seen large pharmaceutical customers stabilize and a rise in ordering patterns from biotech customers.

Antwerp, Belgium, Jan. 28, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT) has sold several ships, resulting in a total profit of 46.52 million USD.

On January 21, 2025, in St. Paul, Minnesota, ScaleReady, along with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, announced that BrainChild Bio has received a G-Rex® Grant worth $300,000.

MINNEAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a leading company in life science tools and reagents, has announced the release of new designer proteins created using advanced AI design methods and protein evolution techniques. This new range from Bio-Techne's R&D Systems brand features IL-2 Heat Stable Agonist, Activin A Hyperactive, and FGF basic Heat Stable, which are available for research purposes and for therapeutic development under good manufacturing practices. Additionally, the portfolio includes Wnt/RSPO1, Wnt/RSPO2, and Wnt/RSPO3 Agonist proteins.

On January 8, 2025, in St. Paul, Minnesota, ScaleReady, along with Wilson Wolf Manufacturing and Bio-Techne Corporation, announced that Seattle Children's Therapeutics, part of the Seattle Children's Research Institute, has received a G-Rex Grant worth $125,000.

Guangzhou, Dec. 19, 2024 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (referred to as “the Company” or “YSXT”), a company based in the Cayman Islands that offers business solutions primarily for insurance firms and brokerages in China, has successfully completed its initial public offering (the “Offering”). They sold 1,250,000 Class A ordinary shares at a price of $4.00 each, raising around $5,000,000 before expenses. The Offering was finalized on December 19, 2024, and the shares began trading on the Nasdaq Capital Market on December 18, 2024, under the ticker “YSXT.”

On December 18, 2024, in St. Paul, Minnesota, ScaleReady, along with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, announced that Moonlight Bio has received a G-Rex® Grant.

Guangzhou, Dec. 17, 2024 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (referred to as “the Company” or “YSXT”), a company based in the Cayman Islands that offers business solutions primarily for insurance firms and brokerages in China, has announced the pricing of its initial public offering (the “Offering”). They will sell 1,250,000 Class A ordinary shares at a price of $4.00 each, aiming to raise about $5,000,000 before expenses. The shares have been approved for listing on the Nasdaq Capital Market and are set to begin trading on December 18, 2024, under the ticker symbol “YSXT.”